Literature DB >> 23512535

The protective effects of ω-3 fatty acids on doxorubicin-induced hepatotoxicity and nephrotoxicity in rats.

Feti Tulubas1, Ahmet Gurel2, Mustafa Oran3, Birol Topcu4, Veli Caglar5, Emine Uygur6.   

Abstract

This study aims to evaluate the protective effects of ω-3 fatty acids (FAs) on doxorubicin (DOX)-induced hepatotoxicity and nephrotoxicity in rats. A total of 24 adult male Sprague Dawley rats were divided into three groups. Control group was given only saline by intragastric gavage. DOX group received DOX at the dose of 30 mg/kg intraperitoneally on day 28. DOX-ω-3 FA group was given as ω-3 FAs at the dose of 400 mg/kg daily by intragastric gavage for 30 days and received DOX at the dose of 30 mg/kg intraperitoneally on day 28. At the end of the 30-day experimental period, the serum, liver and kidney tissue specimens were taken from the animals by giving a general anesthesia. Glutathione (GSH) and malondialdehyde (MDA) levels in serum and GSH and MDA levels and superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities in liver and kidney tissues were measured spectrophotometrically. In our study, a significant increase in MDA levels was observed in rats when given a dose of DOX and a significant decrease in the levels of GSH, SOD and GSH-Px activities in serum, liver and kidney tissues was determined when compared with control group. In addition, a significant decrease in MDA levels was observed in rats when a dose of ω-3 FAs was given with DOX and a significant increase was determined in the levels of GSH, SOD and GSH-Px activities in serum, liver and kidney tissues, when compared with DOX group. We concluded that ω-3 FA had favorable effects in rat liver and kidney tissues by preventing oxidative damage.
© The Author(s) 2013.

Entities:  

Keywords:  Doxorubicin; kidney; liver; oxidative stress; ω-3 fatty acids

Mesh:

Substances:

Year:  2013        PMID: 23512535     DOI: 10.1177/0748233713483203

Source DB:  PubMed          Journal:  Toxicol Ind Health        ISSN: 0748-2337            Impact factor:   2.273


  8 in total

1.  Effect of infliximab, a tumor necrosis factor-alpha inhibitor, on doxorubicin-induced nephrotoxicity in rats.

Authors:  Aly M Abdelrahman; Yousuf M Al Suleimani; Priyadarsini Manoj; Mohammed Ashique; Badreldin H Ali; Nicole Schupp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-09-09       Impact factor: 3.000

Review 2.  Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears.

Authors:  Fernando Ezquer; Jaime Gutiérrez; Marcelo Ezquer; Christian Caglevic; Helio C Salgado; Sebastián D Calligaris
Journal:  Stem Cell Res Ther       Date:  2015-06-24       Impact factor: 6.832

3.  Cytotoxicity of graphene oxide and graphene oxide loaded with doxorubicin on human multiple myeloma cells.

Authors:  Shaoling Wu; Xindong Zhao; Zhongguang Cui; Chunting Zhao; Yuzhen Wang; Li Du; Yanhui Li
Journal:  Int J Nanomedicine       Date:  2014-03-14

4.  The Cooperative Effect of Local Angiotensin-II in Liver with Adriamycin Hepatotoxicity on Mitochondria.

Authors:  Eylem Taskin; Celal Guven; Leyla Sahin; Nurcan Dursun
Journal:  Med Sci Monit       Date:  2016-03-28

5.  Potential Roles of Kleinhovia hospita L. Leaf Extract in Reducing Doxorubicin Acute Hepatic, Cardiac and Renal Toxicities in Rats.

Authors:  Yulia Yusrini Djabir; M Aryadi Arsyad; Sartini Sartini; Subehan Lallo
Journal:  Pharmacognosy Res       Date:  2017 Apr-Jun

6.  Omega-3 fatty acids ameliorate doxorubicin-induced cardiorenal toxicity: In-vivo regulation of oxidative stress, apoptosis and renal Nox4, and in-vitro preservation of the cytotoxic efficacy.

Authors:  Dalia Saleh; Marawan Abdelbaset; Azza Hassan; Ola Sharaf; Sawsan Mahmoud; Rehab Hegazy
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

7.  Nano-Resveratrol: A Promising Candidate for the Treatment of Renal Toxicity Induced by Doxorubicin in Rats Through Modulation of Beclin-1 and mTOR.

Authors:  Ahlam M Alhusaini; Laila M Fadda; Abeer M Alanazi; Wedad S Sarawi; Hatun A Alomar; Hanaa M Ali; Iman H Hasan; Rehab Ahmed Ali
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

8.  Caspase mediated synergistic effect of Boswellia serrata extract in combination with doxorubicin against human hepatocellular carcinoma.

Authors:  Mohammad Ahmed Khan; Mhaveer Singh; Masood Shah Khan; Abul Kalam Najmi; Sayeed Ahmad
Journal:  Biomed Res Int       Date:  2014-08-07       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.